{"Alteplase":{"RelatedTo":["Coagulation factor X","Fibrinogen alpha chain","Urokinase plasminogen activator surface receptor","Plasminogen activator inhibitor 2","Calnexin","Kallikrein-1","Annexin A2","Fibronectin","Laminin subunit alpha-5","Tetranectin","Keratin","type II cytoskeletal 8","Laminin subunit beta-1","Laminin subunit gamma-1","Laminin subunit alpha-1","Calreticulin","Low-density lipoprotein receptor-related protein 1"],"Synonym":["Tissue-type plasminogen activator precursor","t-PA","t-plasminogen activator","tPA"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00009","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00009","Definition":"Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells Pharmacology: Activase binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin. It also produces limited conversion of plasminogen in the absence of fibrin. Mechanism of action: Cleaves the Arg-Val bond in plasminogen to produce active plasmin. Drug type: Approved. Biotech. Drug category: Thrombolytic Agents"}}